Amara Raja Batteries: From Nine-Bagger to a Decade of Stagnation

In the world of stock investing, the journey of Amara Raja Batteries serves as a fascinating case study of market dynamics and investor behaviour. Once celebrated for its remarkable growth, the company experienced a stunning rise from ₹100 to ₹900 per share between 2011 and 2015, showcasing its strong fundamentals and solid performance. However, the following decade brought unexpected challenges, resulting in a prolonged period of stagnation despite the business's underlying strengths. This exploration delves into the factors that shaped its rollercoaster journey, offering insights into the complexities of stock valuation and the market's unpredictability. Through this lens, we can glean valuable lessons for future investment strategies and the enduring hope that informed decisions can still lead to favourable outcomes.

Somany Ceramics: Financial Trauma

What happens when the price becomes more about expectations and less about fundamentals The floor tiles are often the least noticeable aspect inside a building. In the room where I sit and write this, the floor tiles are square and ivory-coloured, with white paint strokes that look like clouds on a sunny day. You are … Continue reading Somany Ceramics: Financial Trauma

Emmbi Industries: Still in Waiting

Emmbi Industries' stock, which had been trading around ₹100, recently spiked to ₹164.50 before plunging 47%. Despite an attractive valuation and growth momentum, significant risks persist, including poor profitability and high debt costs. Continuous monitoring of the stock is crucial, as its future prospects may improve despite current weaknesses.

Rolling With It

The post details the author's investment decisions regarding Vishnu Chemicals, Kovai Medical Centre, and TCPL. It outlines the case for acquiring more shares of Vishnu Chemicals, citing its improved capital structure and favourable core fundamentals despite current stagnant earnings and profitability. Conversely, the author suggests holding off on Kovai Medical Centre due to a recent decline in share price amidst moderating growth and elevated valuation. A complete exit from TCPL is recommended, driven by a significant earnings slowdown and signs of overvaluation. The analysis highlights the importance of core fundamentals in guiding investment choices.

Aries Agro: A Confounding Drawdown

A severe price decline despite improving profitability and low valuation Aries Agro’s stock price performance over the past four months has been underwhelming and clearly incommensurate with recent improvements in its fundamentals. Its operating revenue had doubled over the past five years; revenue growth averaged more than 15% over the past seven quarters; operating profit … Continue reading Aries Agro: A Confounding Drawdown

RACL Geartech: Prospects have Got Better

The September 2025 quarter’s performance has notably enhanced RACL Geartech’s investment outlook. The stock exhibits strong cash flows and capital allocation, along with solid gross profit margins. The earnings slowdown, which had been a significant burden on the stock for some time, appears to have concluded with the positive earnings turnaround in the latest quarter. Our DCF valuation suggests a fair value of ₹805 per share, while the current market price of ₹1,000 per share indicates a 24% premium to this estimate. We generally consider it acceptable to buy if the premium remains below 25%.

Cantabil Retail: A Stock to Watch

Cantabil Retail has shown promising signs of recovery after three years of price stagnation and earnings slowdown. With improved financial results and a notable increase in earnings per share, this apparel retailer is positioned for growth. The stock, trading around ₹250, presents a potential opportunity, especially as its valuation remains reasonable against a backdrop of rising profit margins. This analysis explores Cantabil's fundamentals, market performance, and prospects.

L G Balakrishnan & Bros: End of a Sabbatical

L G Balakrishnan & Bros (LGBB) has shown a remarkable turnaround in its financial performance, as evidenced by a substantial increase in its stock price and improved profitability metrics. Initially, the stock stagnated despite consistent earnings growth, but it surged 35% to ₹1,900 per share in November 2025, driven by impressive quarterly results. While key metrics such as gross profit margins and capital expenditures show promise, concerns about asset allocation and profitability remain. This analysis explores the factors influencing LGBB's recent performance and its long-term outlook.